New research has found that testosterone treatments for men could cause an increased risk of stroke, heart attack or even death. Men with signs of heart problems were more likely to suffer a stroke, heart attack or die while taking testosterone supplements. Additionally, younger men with a history of heart disease were three times as likely to suffer a stroke or heart attack while taking the therapy. The study examined medical records of 56,000 men after they filled a prescription for testosterone treatment.
The study was published in PLOS ONE, an international, peer-reviewed online publication in January, 2014. It is a part of the growing body of research that raises concerns about the increased risk associated with taking testosterone therapy.
In 2011, more than 5 million prescriptions for testosterone were written in the United States, according to news reports. Testosterone therapy is most often administered as a gel, patch or injection. The following products treat low testosterone:
The pharmaceutical attorneys, led by named shareholders Paul Hanly and Jayne Conroy, at the firm are currently investigating claims regarding certain testosterone therapies. If you or a loved one has suffered a heart attack, congestive heart failure or stroke while receiving testosterone therapy, you may be eligible to file a claim. Our attorneys are available to evaluate your potential case.
File a Low Testosterone Therapy Lawsuit
If you are currently undergoing treatments for low testosterone or testosterone therapy, discuss the increased risk of heart problems with your doctor. Do not stop taking any medication until you have discussed the risks and benefits of doing so with your health care provider.
The pharmaceutical attorneys at Simmons Hanly Conroy are currently investigating legal claims regarding men who suffered a stroke, heart attack or even died while taking low T treatments or testosterone therapy. If you or a loved one has been injured while taking low testosterone treatments, you may be able to file testosterone lawsuits. In July 2014, Shareholder Trent Miracle was appointed as co-lead counsel in the national multidistrict litigation pending against the manufacturers of testosterone therapy replacement treatments by the Honorable Matthew F. Kennelly, of the U. S. District Court for the Northern District of Illinois. Contact our experienced lawyers today.